Dear John,

Ottawa’s changes to the Patented Medicines Regulations are intended to reduce drug prices.

But a new study published by the Fraser Institute today finds that these changes will also likely result in delayed – or worse, limited – access to new life-saving medicines.

The potential lower prices will discourage pharmaceutical companies from launching new products in Canada, and reduce the financial incentives to develop and manufacture new medicines, treatments, and cures in Canada.

Worth noting is that COVID-19 vaccines were effectively exempt from regular pricing oversight, suggesting that the federal government is aware of the discouraging effect such restrictions have on innovation in the pharmaceutical industry.

Check out the full study here [[link removed]], and please share this important information on social media!

Sincerely,

Niels Veldhuis

President

The Fraser Institute

STAY UP TO DATE

SUPPORT THE FRASER INSTITUTE

The Fraser Institute has been ranked the #1 think tank in Canada, and the 14th best think tank out of more than 8,200 around the world! We keep Canadians – and decision-makers! – informed.

But we are only as strong as our supporters. We do not accept government grants or payments for research - we depend on individuals like you to continue our good work! We are a charity - your donation entitles you to a generous tax credit at tax time!

Contact Us [[link removed]] Privacy Policy [[link removed]] Unsubscribe [link removed] The Fraser Institute's mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. Email is one of the best tools we have to accomplish these goals. If you no longer wish to receive e-mail updates from us, click here to unsubscribe [link removed].

Fraser Institute 4th Floor, 1770 Burrard Street Vancouver, BC V6J 3G7